Funder: American Association for Cancer Research
Due Dates: March 12, 2026 (Full application, 1:00 p.m. U.S. Eastern)
Funding Amounts: $50,000 total for a 1-year project; no indirect costs allowed.
Summary: Supports innovative basic, translational, or clinical research on druggable targets or biomarkers to advance new kidney cancer treatments.
Key Information: Applicants must be AACR Active members in good standing at an academic or non-profit institution.